Cystic and cavitating lung lesions as a presenting finding of metastatic prostate cancer
Authors: Michael A Cilento and Christopher M Hocking
Published online: 7 June 2021
A 56-year-old man presented with cough, dyspnoea and urinary symptoms

A 56‐year‐old man presented with cough, dyspnoea and urinary symptoms. He was prescribed antibiotics and, when the symptoms did not improve, a computed tomography (CT) scan was ordered. The CT scan showed innumerable cavitating, cystic and solid lesions throughout both lungs, predominantly affecting the upper zones (Figure, A and B). Differential diagnosis for multiple cavitating and cystic lung lesions includes malignant, infective, vascular and inflammatory causes. Pulmonary metastases can occur secondary to a variety of primary cancers; cavitation may be suggestive of squamous cell carcinomas or less commonly sarcomas or adenocarcinomas.1
Bone scan showed metastatic disease. Prostate‐specific antigen (PSA) blood test result was elevated to 199 µg/L (reference interval, 0.3–4.0 µg/L). Core biopsies of a lung lesion revealed metastatic prostate adenocarcinoma.
The patient started androgen deprivation therapy and received standard of care treatment with six cycles of docetaxel chemotherapy,2 with a reduction in PSA to 0.05 µg/L and a marked improvement in the multiple pulmonary lesions on CT scan (Figure, C and D).
Competing interests
No relevant disclosures.
References
- Seo JB, Im JG, Goo JM, et al. Atypical pulmonary metastases: spectrum of radiologic findings. Radiographics 2001; 21: 403–417.
- Kyriakopoulos CE, Chen YH, Carducci MA, et al. Chemohormonal therapy in metastatic hormone‐sensitive prostate cancer: long‐term survival analysis of the randomized phase III E3805 CHAARTED trial. J Clin Oncol 2018; 36: 1080–1087.